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Is Human Immunodeficiency Virus Infection a Risk Factor
for Strongyloides stercoralis Hyperinfection and
Dissemination?
Marc O. Siegel, Gary L. Simon*
Division of Infectious Diseases, George Washington University Medical Center, Washington, DC, United States of America
Strongyloides stercoralis was first identified
in post-mortem examination of the gas-
trointestinal tract of five French soldiers
from Cochin, China, in 1876. Since then it
has been recognized that infection with
this organism can persist for decades. This
is due to an autoinfective process whereby
rhabditiform larvae that are excreted by
the adult worm are converted to infectious
filariform larvae in the large intestine
where they can then reinfect the host.
Under normal conditions this conversion
in humans is quite limited, with most
conversions occurring in the soil. Occa-
sionally large numbers of rhabditiform
larvae transform into infective filariform
larvae in the human gastrointestinal tract,
which results in a more severe form of the
autoinfective cycle. This is referred to as
hyperinfection syndrome and can result in
dissemination of the larvae to other organs
in the host with potentially fatal conse-
quences.
The hyperinfection syndrome has been
linked to immunosuppression. In particu-
lar, conditions that impact on cell-mediat-
ed immunity have been more closely
identified as risk factors for the develop-
ment of this syndrome. The two conditions
that have been most frequently recognized
as predisposing factors for the develop-
ment of the hyperinfection syndrome are
corticosteroid use [1,2] and human T-
lymphotropic virus type 1 (HTLV-1)
infection [3]. Studies of disseminated
disease in organ transplant patients, asth-
matics, patients with chronic lung disease,
and patients with autoimmune disease
have shown that corticosteroid therapy
has been a common denominator in the
development of severe infection.
When acquired immune deficiency
syndrome (AIDS) was first described, it
was predicted that there would be an
outbreak of disseminated strongyloidiasis,
especially in patients from the developing
world, where S. stercoralis is endemic. Prior
to the recognition of the human immuno-
deficiency virus (HIV), the diagnosis of
AIDS was based on the presence of a
selected group of opportunistic infections
in patients who had no other identifiable
predisposing condition. Disseminated
strongyloidiasis was among this list of
opportunistic infections. These initial con-
cerns do not appear to have been
warranted. In necropsy studies in HIV-
infected patients in both Brazil and Africa,
areas where the incidence of strongyloidi-
asis is high, there was not a single case of
disseminated disease [4,5]. Although it is
possible that cases might have gone
unrecognized, since clinical monitoring in
those parts of the world where strongyloi-
diasis is endemic might have been less
comprehensive than in more developed
areas, the relative paucity of cases led the
CDC and the WHO to remove dissemi-
nated strongyloidiasis from its list of
signature infections in 1987. Since then
there have been only 40 cases of hyperin-
fection and disseminated strongyloidiasis
in HIV-infected individuals reported in
the medical literature. Most of these
individuals had AIDS and many were also
receiving corticosteroids.
Of note, HIV infection does not protect
individuals from acquiring intestinal stron-
gyloidiasis. Several studies have docu-
mented increased rates of S. stercoralis
infection among HIV-infected individuals.
Assefa et al. found a 21-fold increased
prevalence of S. stercoralis infection among
HIV-positive compared to HIV-negative
patients in southern Ethiopia [6]. Studies
in Brazil have shown similar results [7].
However, this increased predilection for
intestinal S. stercoralis infection among
HIV-infected individuals does not seem
to be predictive of an increased incidence
of hyperinfection and dissemination.
The predominant immunosuppressive
effect of HIV infection is a cellular
immune deficiency as evidenced by a
progressive decline in CD4+ lymphocytes.
However, within the CD4+ cell popula-
tion, there is a relatively greater decline in
the activity of the type 1 T helper (Th1)
cells than the type 2 T helper (Th2) cells
[8,9]. Th1 cells produce a variety of pro-
inflammatory cytokines that modulate the
cellular immune response including inter-
feron gamma (IFN-c), interleukin 2 (IL-2),
and tumor necrosis factor alpha (TNF-a)
[10]. Th2 cells, on the other hand, are
more active in mediating humoral immu-
nity and produce cytokines IL-4, IL-5, IL-
10, and IL-13. The concept of a Th1 to
Th2 cytokine shift in the course of HIV
infection has been advanced by some
investigators as a marker for HIV progres-
sion [10]. Others have not confirmed these
findings and they remain somewhat con-
troversial [11]. Nevertheless, whereas
there is profound loss of Th1 immune
activity in patients with advanced AIDS,
there may be little change in Th2-
mediated cytokine activity. Indeed, levels
of the Th2 cytokines IL-4 and IL-10 have
been found to be higher in HIV-infected
patients, both with and without opportu-
nistic infections, than in uninfected con-
trols [12]. The potential consequence of
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this is that for many co-infected patients,
the Th2-mediated response to helminthic
infections may be conserved.
In general, the Th2 immune response is
dominant in patients with helminthic
infections. IL-4 and IL-5 stimulate IgE
production, which in turn causes mast cells
to degranulate and goblet cells to secrete
mucous [13]. The mucous facilitates
trapping and expulsion of the helminths,
while mast cells prevent attachment and
invasion of the worms to the intestinal wall
and promote peristalsis to aid in the
expulsion of the parasites [14]. IL-5 also
stimulates the production, migration, and
activation of eosinophils [14].
Another Th2-mediated cytokine, IL-5,
acts as an eosinophil colony stimulating
factor. Eosinophils play a major role in
host defense against helminthic infections.
Killing of parasites is due to the release of
eosinophilic cytoplasmic granules on the
surface of the eosinophils. Eosinophils are
directly involved not only in the innate
immune response to the helminthic larvae,
but also in eliciting an adaptive immune
response. Padigel et al. demonstrated that
eosinophils act as antigen-presenting cells
when exposed to S. stercoralis antigens,
thereby stimulating antigen-specific Th2
cytokine production [15].
Elevated IgE levels are commonly
found in patients with helminthic infec-
tions, and type-specific anti-Strongyloides
IgE antibody has been demonstrated in
patients with S. stercoralis infection [16].
HIV infection is also associated with high
IgE levels, with higher levels found in
patients with more advanced infection;
that is, those with lower CD4+ cell counts
[17]. There is evidence to suggest that
HIV infection promotes the production of
IL-4 and IL-13, B-cell growth factors.
HIV-1 glycoprotein 120 (gp120) is a
potent stimulus for release of these cyto-
kines through an interaction with the VH3
region of IgE that is bound to the FceRI
region on basophils and mast cells [18]. In
fact, it has been suggested that HIV gp120
acts as an allergen promoting increased
production of IgE [19]. Whether the
elevated IgE levels found in co-infected
patients are type-specific and whether this
is a key factor in preventing dissemination
have not been demonstrated, but this is an
area for further investigation.
Helminthic infections themselves pro-
mote immune activation leading to im-
mune dysregulation and result in a
decrease in CD4+ lymphocytes and an
increase in CD8+ cells [20,21]. However,
the observed loss in CD4+ cells in patients
with helminthic infections does not reach
the level seen in HIV infection. The role of
helminthic induced immune activation
and its relationship to the development
of vaccines against S. stercoralis and other
helminths is a potential fertile area for
further research.
In contrast to the relatively preserved
Th2 activity associated with HIV infec-
tion, individuals infected with HTLV-1, a
retrovirus that has been associated with an
increased risk of disseminated strongyloi-
diasis, have an immunologic shift to a Th1
cell type response. HTLV-1-infected lym-
phocytes produce increased levels of IFN-
c and reduced levels of IL-4 and IL-5 [22].
Mitogen-stimulated PBMCs from HTLV-
1-infected patients infected with S. stercor-
alis produce higher levels of IFN-c and
lower levels of IL-4 than control patients
[23]. In these patients total serum IgE
levels were inversely correlated with mito-
gen-stimulated IFN-c production in these
patients. S. stercoralis-specific IgE levels
were also reduced, but the correlation
did not reach statistical significance.
Treatment of HIV infection is often
associated with improvement in the host
non-specific inflammatory response.
There have been only five cases of
immune reconstitution inflammatory syn-
drome (IRIS) reported in patients with S.
stercoralis infection [24]. Three of these
patients had a syndrome that was consis-
tent with disseminated infection, but two
of these patients had received courses of
corticosteroids prior to their diagnosis,
making it unclear whether their infection
was precipitated by the IRIS.
There are a number of unanswered
questions regarding this topic. The first is
that the underlying presumption that HIV
does not lead to disseminated infection is
based on the absence of data as well as the
WHO and CDC list of signature infections
that have been associated with HIV. Proof
that something does not exist is difficult,
but until such data are available, the
current epidemiology does suggest that
HIV is not a risk factor for disseminated
strongyloidiasis. The impact of HIV on
the susceptibility to infection with S.
stercoralis is not well-defined. Does chronic
immune activation make one more sus-
ceptible to S. stercoralis? What is the relative
role of IgE antibodies, eosinophils, and/or
other Th2-mediated activity in preventing
dissemination? Further study on the im-
mune interaction between HIV, S. stercor-
alis, and other helminths may provide
useful insight into the development of
helminthic vaccines.
In summary, despite the fact that HIV
and glucocorticosteroids are viewed as
similar cell-mediated immune suppres-
sants, their immunosuppressive activities
are quite different. HIV infection results,
primarily, in a loss of Th1 activity. In
comparison, Th2 activity in the HIV-
infected individual may be impaired to a
much lesser degree, or may even be
augmented. This does not necessarily
indicate that infection with HIV actually
leads to enhanced activity specifically
against S. stercoralis or even that the HIV-
infected host has the equivalent anti-
Strongyloides activity as an immunologically
normal individual. However, it may be the
Th2 activity in the HIV host helps to
prevent dissemination of S. stercoralis in the
HIV-infected population.
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